MMI completes Series C financing led by Fidelity
MMI completed Series C financing led by Fidelity Management & Research Company to expand Symani commercialization and clinical evidence.
Evidence notes
- All existing investors participated in the financing.
- The capital was allocated to high-growth-market commercialization, indication-expansion studies, advanced technology and global operations.
- The round extended the company’s funding base for microsurgery product and market expansion.
Company overview
Surgical-robotics company developing the Symani system for microsurgery and supermicrosurgery.